Background: The term “skin booster” is commonly referred to in dermatology. These products may comprise several components, including exosomes, secretomes, chitosan, polydeoxyribonucleotide, platelet-rich plasma, and hyaluronic acid. In today’s world, the use of such products is not confined to aesthetic purposes; they are also used to treat several other skin conditions. This review paper highlights the role of “skin booster" components for different skin disorders based on their in vitro, in vivo, and clinical studies. Discussion: “Skin boosters” are bioactive agents typically administered into the dermal layer. Understanding the mechanisms of each component is important because their applications extend beyond skin revitalization to include other forms of therapeutic revitalization. These findings suggest the possibility of a new treatment strategy. Currently, emerging evidence suggests that “skin boosters” have applications beyond aesthetics, particularly as an adjuvant therapy to improve skin integrity, reduce inflammation, and enhance tissue regeneration. Conclusion: Research on the components of “skin boosters" may be used to treat various skin diseases. However, their use should remain adjunctive, as current evidence is insufficient to support first-line treatment. Clinical trials, appropriate patient selection, and application guidelines must be established to enhance the scientific validity and rationale for this treatment modality.